Iantrek
Latest round
- Series C
Last raised
- Aug 2025
Total raised
- $50M
Investors
- 6
About Iantrek
Based in New York, US, and founded in 2019, Iantrek operates as an ophthalmic medical device company. The company was founded by its CEO Sean Ianchulev. In August 2025, Iantrek, Inc. Iantrek develops various medical devices, including micro-interventional glaucoma surgical (MIGS) devices. The MIGS products are focused on the applications of aqueous outflow pathways, trabecular and suprachoroidal. The company’s product line includes CycloPen™, a micro-interventional device that focuses on the suprachoroidal outflow channel; and Hydrus® Microstent.
Who invested in Iantrek
6 investors across 2 rounds
See all investors in Iantrek
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Iantrek
Who invested in Iantrek?
Iantrek has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Iantrek raised?
Iantrek has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Iantrek last raise money?
Iantrek's most recent round on record is a Series C, in Aug 2025.
What does Iantrek do?
Based in New York, US, and founded in 2019, Iantrek operates as an ophthalmic medical device company.
Where is Iantrek headquartered?
Iantrek is headquartered in White Plains, US.
Which VCs invest in companies like Iantrek?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Iantrek's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Iantrek? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.